SCHEMBL7982878

SCHEMBL7982878

COc1ccc(-c2ccc(-c3nc(C4=CC=CCC4=S)c(NC(=O)c4ccccc4)o3)c(O)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.44
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 3/20 0.44
HPGD P15428 3/20 0.44
POLB P06746 2/20 0.44
HSD17B10 Q99714 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
GAA P10253 1/20 0.44
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
KDR P35968 3/20 0.43
TSHR P16473 1/20 0.43
HDAC2 Q92769 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
FLT1 P17948 1/20 0.40
FLT4 P35916 1/20 0.40
ABCG2 Q9UNQ0 1/20 0.39
THRB P10828 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7744779 0.93 KDR (0.43) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL7979629 0.91 KDR (0.39) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL7987348 0.87 KDR (0.44) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL7744196 0.85 KDR (0.54) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL7744761 0.84 HPN (0.46) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL7980106 0.83 KDR (0.42) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL7744056 0.80 HPGD (0.42) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL7980768 0.80 KDR (0.45) MAPTMEN1KMT2AKDM4EPOLB
SCHEMBL7738993 0.79 KDR (0.55) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL7986670 0.77 KDR (0.50) SMN1; SMN2NPC1RAB9AKDRTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US claimed